Protocol ICAC-30 Mechanisms Underlying Asthma Exacerbations Prevented and Persistent with Immune-Based Therapy: A Systems Approach Phase 2
Sponsor: |
NIAID |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAR4384 |
U.S. Govt. ID: |
NCT03292588 |
Contact: |
Marcela Pierce: 347-344-3000 / mp2648@cumc.columbia.edu |
Research funded by the NIH is being done to learn if an asthma medication, given along with standard asthma care, makes children less likely to have asthma attacks.
This study is closed
Investigator
Meyer Kattan, MD
Is your child between 6 and 18 years of age? |
Yes |
No |
Does your child have asthma? |
Yes |
No |
Has your child had 2 or more asthma attacks in the last year? |
Yes |
No |
Does your child take asthma medication daily? |
Yes |
No |